1 week Ago By ABMN Staff
STAAR Surgical ( NASDAQ:STAA – Get Free Report ) major shareholder Broadwood Partners, L.P. bought 138,054 shares of STAAR Surgical stock in a transaction on Monday, April 7th.
The shares were purchased at an average cost of $15.61 per share, with a total value of $2,155,022.94.
Following the acquisition, the insider now directly owns 13,332,264 shares of the company’s stock, valued at approximately $208,116,641.04. The trade was a 1.
05 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link . Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Broadwood Partners, L.P. also recently made the following trade(s): STAAR Surgical Trading Down 6.
5 % Shares of NASDAQ:STAA opened at $15.09 on Wednesday. The company has a market cap of $744.
31 million, a PE ratio of -36.80 and a beta of 0.75.
The company’s 50 day moving average is $18.27 and its two-hundred day moving average is $24.38.
STAAR Surgical has a 52 week low of $13.50 and a 52 week high of $52.68.
Wall Street Analyst Weigh In View Our Latest Analysis on STAA Institutional Inflows and Outflows A number of hedge funds have recently modified their holdings of the stock. Quarry LP acquired a new position in STAAR Surgical during the third quarter worth approximately $50,000. FMR LLC grew its position in shares of STAAR Surgical by 79.
3% during the third quarter. FMR LLC now owns 7,092 shares of the medical instruments supplier’s stock worth $263,000 after acquiring an additional 3,136 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of STAAR Surgical in the 4th quarter valued at $180,000.
HighTower Advisors LLC purchased a new stake in STAAR Surgical in the 3rd quarter valued at $336,000. Finally, Bridgefront Capital LLC boosted its stake in STAAR Surgical by 27.2% during the 4th quarter.
Bridgefront Capital LLC now owns 10,792 shares of the medical instruments supplier’s stock worth $262,000 after purchasing an additional 2,306 shares during the period. 96.70% of the stock is owned by hedge funds and other institutional investors.
STAAR Surgical Company Profile ( Get Free Report ) STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. Recommended Stories Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.
com's FREE daily email newsletter ..
